August 19, 2026 08:30 ET  | Source: Teva Pharmaceutical Industries Ltd PARSIPPANY, N.J. and TEL AVIV, Israel, Aug. 19, 2026 (GLOBE NEWSWIRE) — Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced that the U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for ecopipam, with a

August 18, 2026 16:00 ET  | Source: Oil-Dri Corporation Of America CHICAGO, Aug. 18, 2026 (GLOBE NEWSWIRE) — Amlan International, the animal health business of Oil-Dri Corporation of America, will serve as the Technical Symposium Sponsor at the 2026 Arkansas Nutrition Conference in Little Rock, Arkansas. The Amlan-sponsored symposium will take place Tuesday, August 25, from 1:00–5:00

August 18, 2026 03:01 ET  | Source: Smith & Nephew UK Ltd Marking a new approach to innovation in medical robotics, the new centre will bring advances from a leading surgical robotics research group to patients more quickly Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, and Imperial College London have launched a five-year partnership to deliver

Launching with a $4 million Seed round led by Founders Fund, GAMGEE is bringing personalized cancer care to dogs August 17, 2026 15:00 ET  | Source: GAMGEE A Media Snippet accompanying this announcement is available by clicking on this link. SYDNEY, Aug. 17, 2026 (GLOBE NEWSWIRE) — Rosie was given only months to live. Her owner, Paul

August 17, 2026 08:00 ET  | Source: Smith & Nephew UK Ltd Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces a breakthrough in RF resection technology for hip with its new FLOW FLEXTEND COBLATION Wand. Designed as an extension of its proprietary FLOW~IQ◊ technology with an adjustable-angle tip, the FLOW FLEXTEND Wand is designed to give

August 14, 2026 16:55 ET  | Source: Optimi Health Corp. VANCOUVER, British Columbia, Aug. 14, 2026 (GLOBE NEWSWIRE) — Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the “Company” or “Optimi”), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced that it has entered into a common shares purchase agreement (the “Purchase Agreement”) with

August 12, 2026 07:30 ET  | Source: Adagene Inc. Randomized Phase 2 trial in microsatellite stable colorectal cancer (MSS CRC) ongoing, with results expected in 1H 2027; potential registration trial expected in 2027 once recommended dose regimen has been established  Data reported at AACR from triple combination therapy in 1L hepatocellular carcinoma (HCC) and late-line MSS CRC

August 11, 2026 15:47 ET  | Source: Egg Medical, Inc. ST. PAUL, Minn., Aug. 11, 2026 (GLOBE NEWSWIRE) — Egg Medical announced today that Rampart IC, LLC (“Rampart”) withdrew its appeal of the USPTO’s reexamination decision that the claims of Rampart’s U.S. Patent No. 11, 660,056 as originally granted were invalid. The USPTO’s invalidation is based on grounds that

August 11, 2026 08:00 ET  | Source: Teva Pharmaceutical Industries Ltd TEL AVIV, Israel, Aug. 11, 2026 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Moody’s Ratings has upgraded Teva’s corporate credit rating to Baa3 from Ba1, an investment-grade rating, with a stable outlook.  Moody’s states that the upgrade reflects the

August 11, 2026 07:00 ET  | Source: Dark Horse Consulting Group WALNUT CREEK, Calif. and SHANGHAI, Aug. 11, 2026 (GLOBE NEWSWIRE) — Dark Horse Consulting Group (DHCG), a leading life sciences consulting firm specializing in advanced therapies, today announced the formation of Dark Horse Consulting China and the appointment of Kang Liu, Ph.D. as its inaugural hire.

August 11, 2026 06:00 ET  | Source: Zymeworks Inc. VANCOUVER, British Columbia, Aug. 11, 2026 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel, multifunctional biotherapeutics, today announced that management will participate in the following upcoming investor conferences: About Zymeworks Inc. Zymeworks

August 11, 2026 05:00 ET  | Source: Boehringer Ingelheim Boehringer Ingelheim announced today that it has acquired Evax AG, a Swiss biotech company focused on equine health. Founded more than a decade ago at the University of Zurich, Evax has been exploring the use of therapeutic vaccines to address significant unmet needs in horses, particularly for the treatment of allergic skin

August 11, 2026 02:00 ET  | Source: Royal Philips August 11, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Exor N.V. today announced that they have agreed to update their long-term relationship agreement.  It provides Exor with the flexibility to increase its shareholding in Philips to up

The intelligent sleep wearable combines 3D light-blocking technology, adjustable temperature control, and immersive audio to create a personalized sleep environment. August 10, 2026 23:21 ET  | Source: DR H HONG KONG, Aug. 11, 2026 (GLOBE NEWSWIRE) — Smart wearable brand DR H has officially launched the Mind Ease Mask, an intelligent sleep wearable integrating light management, temperature control, and

Next-generation all-in-one performance supplement brand, built on a radical athlete co-ownership model, opens pre-sales ahead of September 2026 product launch August 10, 2026 20:00 ET  | Source: NORTH Performance DOVER, Del., Aug. 10, 2026 (GLOBE NEWSWIRE) — NORTH Performance, a next-generation all-in-one performance supplement brand built on the radical premise that athletes shouldn’t be ambassadors; they should